Search - tctmd.com

Displaying 1 - 20 of 93

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

Presentation TCT 2021

Role of Drug Eluting Technologies as Definitive Therapy

Presenter: Thomas Zeller

November 06, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News LINC 2020

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

L.A. McKeown

February 06, 2020

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

Presentation TCT 2019

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

Presenter: Thomas Zeller

September 27, 2019

Presentation TCT 2019

My Toughest BTK Case of the Year

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Presenter: Thomas Zeller

September 25, 2019

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

Presentation TCT 2017

DCB Under Development: Alternative Drugs and Local Delivery Methods

Presenter: Sahil A. Parikh, Thomas Zeller, William A. Gray

November 01, 2017

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

DCB for Long Lesions and Highly Calcified Vessels II: Are Outcomes Improved With Non-Atherectomy Approaches (Scoring, Cutting, Lithoplasty, and More)

Presenter: Sahil A. Parikh, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

DCB for Long Lesions and Highly Calcified Vessels I: Are Outcomes Improved by Routine Atherectomy?

Presenter: Sahil A. Parikh, Thomas Zeller, Krishna J. Rocha-Singh

November 01, 2017

Presentation TCT 2017

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

Presenter: Sahil A. Parikh, Thomas Zeller

November 01, 2017

Presentation TCT 2017

DCB Data in Real-world Registries: Back to Reality?

Presenter: Sahil A. Parikh, Thomas Zeller, Gary M. Ansel

November 01, 2017

Advertisement

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Role of Drug Eluting Technologies as Definitive Therapy

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

My Toughest BTK Case of the Year

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Veryan Medical receives PMA approval for BioMimics 3D

SELUTION™ First-in-Man Study Achieves Primary Endpoint

DCB Under Development: Alternative Drugs and Local Delivery Methods

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

DCB for Long Lesions and Highly Calcified Vessels II: Are Outcomes Improved With Non-Atherectomy Approaches (Scoring, Cutting, Lithoplasty, and More)

DCB for Long Lesions and Highly Calcified Vessels I: Are Outcomes Improved by Routine Atherectomy?

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

DCB Data in Real-world Registries: Back to Reality?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content